English | 简体中文 | 繁體中文 | 한국어
 All Press Releases
 Medicine Clinical Trials
Avance Clinical CEO Joins Global BioPharma Panel for Evolution Europe Summit 2023
Apr 18, 2023 11:00 HKT
아방스 임상 CEO, 에볼루션 유럽 서밋 2023의 글로벌 바이오파마 패널에 참가
Apr 18, 2023 11:00 HKT
Avance Clinical 首席执行官加入 2023 年欧洲进化峰会 全球生物制药小组
Apr 18, 2023 11:00 HKT
Avance Clinical 首席執行官加入 2023 年歐洲進化峰會 全球生物製藥小組
Apr 18, 2023 11:00 HKT
HanchorBio Announces US IND Clearance for the Multi-Regional Clinical Trial of HCB101 to Treat Solid and Hematological Malignancies
Apr 17, 2023 19:30 HKT
亿胜生物与Osteopore签订口腔颌面产品在新加坡的独家代理协议
Apr 14, 2023 17:20 HKT
億勝生物與Osteopore簽訂口腔頜面產品在新加坡的獨家代理協議
Apr 14, 2023 17:19 HKT
Essex and Osteopore Entered into Exclusive Distribution Agreement for Oral Maxillofacial products in Singapore
Apr 14, 2023 17:18 HKT
亿胜生物与郡是深圳签订皮耐克®可吸收性敷料在中国大陆的独家代理协议
Apr 11, 2023 13:00 HKT
億勝生物與郡是深圳簽訂皮耐克®可吸收性敷料在中國大陸的獨家代理協議
Apr 11, 2023 12:59 HKT
Essex and Gunze Shenzhen Entered into Exclusive Agency Agreement for PELNAC Absorbable Dressing in Mainland China
Apr 11, 2023 12:58 HKT
TrialWire Patient Recruitment Platform Launches AI Pre-recruit to Cut Recruitment Time by 50%
Apr 11, 2023 08:00 HKT
冠科美博(Apollomics Inc.)宣布完成和SPAC Maxpro合并,并在纳斯达克上市
Mar 30, 2023 20:31 HKT
冠科美博(Apollomics Inc.)宣佈完成和SPAC Maxpro合併,並在納斯達克上市
Mar 30, 2023 20:30 HKT
Apollomics, a Company Developing Novel Oncology Therapies to Address Difficult-to-Treat Cancers, Announces Closing of Business Combination and Listing on Nasdaq
Mar 30, 2023 20:29 HKT
Singapore family cord blood bank Cryoviva upgrades to AXP II System for cord blood processing
Mar 21, 2023 08:30 HKT
亿胜生物公布2022年度业绩
Mar 08, 2023 20:30 HKT
億勝生物公布2022年度業績
Mar 08, 2023 20:29 HKT
Essex Bio-Technology Announces 2022 Annual Financial Results
Mar 08, 2023 20:28 HKT
“天然分子” 的葫蘆裡,給慢病埋的什麼藥?
Mar 03, 2023 09:48 HKT
<< Previous  Next >>
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: